Clinical Trials Directory

Trials / Terminated

TerminatedNCT01395394

Phenylketonuria, Oxidative Stress, and BH4

The Ability of Kuvan® (Sapropterin Dihydrochloride) to Prevent Meal-induced Lipid Peroxidation and Endothelial Dysfunction in Patients With Phenylketonuria: a Pilot Study

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Emory University · Academic / Other
Sex
All
Age
10 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to see how tetrahydrobiopterin therapy (BH4; also known as sapropterin dihydrochloride or Kuvan) affects measures of oxidative stress and endothelial function in patients with Phenylketonuria (PKU).

Detailed description

Oxidative stress will be induced by having participants eat a meal in polyunsaturated fats. The investigators will see how participants respond to the meal challenge over the course of 6 hours. * PKU participants who are currently on BH4 therapy will be evaluated while taking BH4 with the meal at a single study visit. * PKU participants who did not responded to BH4 therapy will be evaluated twice. At the first study visit the investigators will see how you react to the meal challenge when you are not given BH4. You will be given BH4 for two weeks, then return for a second meal challenge study visit while taking BH4. * Healthy controls will be evaluated after consuming the meal only (no BH4) at a single study visit.

Conditions

Interventions

TypeNameDescription
DRUGKuvanParticipants in the BH4 Non-Responder group will be given a 20 mg/kg body weight/day dose of Kuvan to take on a daily basis for two weeks. The last dose will be administered at the participant's study visit 2.
OTHERMeal ChallengeAt each study visit, patients will receive a meal high in polyunsaturated fats that will promote a transitory increase in oxidative stress measures and endothelial dysfunction

Timeline

Start date
2011-06-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2011-07-15
Last updated
2014-08-28
Results posted
2014-08-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01395394. Inclusion in this directory is not an endorsement.